These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 16393339

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Chromosome number and carmustine sensitivity in human gliomas.
    Shapiro JR, Pu PY, Mohamed AN, Galicich JH, Ebrahim SA, Shapiro WR.
    Cancer; 1993 Jun 15; 71(12):4007-21. PubMed ID: 8389658
    [Abstract] [Full Text] [Related]

  • 4. BCNU-resistant human glioma cells with over-representation of chromosomes 7 and 22 demonstrate increased copy number and expression of platelet-derived growth factor genes.
    Scheck AC, Mehta BM, Beikman MK, Shapiro JR.
    Genes Chromosomes Cancer; 1993 Nov 15; 8(3):137-48. PubMed ID: 7509621
    [Abstract] [Full Text] [Related]

  • 5. BCNU-sensitivity in parental cells and clones from four freshly resected near-diploid human gliomas: an astrocytoma, an anaplastic astrocytoma and two glioblastomas multiforme.
    Shapiro JR, Ebrahim SA, Mohamed AN, Pu PY, Shapiro WR.
    J Neurooncol; 1993 Mar 15; 15(3):209-27. PubMed ID: 8395568
    [Abstract] [Full Text] [Related]

  • 6. Gene expression profile induced by BCNU in human glioma cell lines with differential MGMT expression.
    Bandres E, Andion E, Escalada A, Honorato B, Catalan V, Cubedo E, Cordeu L, Garcia F, Zarate R, Zabalegui N, Garcia-Foncillas J.
    J Neurooncol; 2005 Jul 15; 73(3):189-98. PubMed ID: 15980968
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Identification of transforming growth factor-beta1-binding protein overexpression in carmustine-resistant glioma cells by MRNA differential display.
    Norman SA, Rhodes SN, Treasurywala S, Hoelzinger DB, Rankin Shapiro J, Scheck AC.
    Cancer; 2000 Aug 15; 89(4):850-62. PubMed ID: 10951349
    [Abstract] [Full Text] [Related]

  • 13. Redox proteomics reveal stress responsive proteins linking peroxiredoxin-1 status in glioma to chemosensitivity and oxidative stress.
    Poschmann G, Grzendowski M, Stefanski A, Bruns E, Meyer HE, Stühler K.
    Biochim Biophys Acta; 2015 Jun 15; 1854(6):624-31. PubMed ID: 25484280
    [Abstract] [Full Text] [Related]

  • 14. Inducible nitric oxide synthase neutralizes carbamoylating potential of 1,3-bis(2-chloroethyl)-1-nitrosourea in c6 glioma cells.
    Yin JH, Yang DI, Chou H, Thompson EM, Xu J, Hsu CY.
    J Pharmacol Exp Ther; 2001 Apr 15; 297(1):308-15. PubMed ID: 11259558
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Epithelial-to-mesenchymal transition is involved in BCNU resistance in human glioma cells.
    Yan YR, Xie Q, Li F, Zhang Y, Ma JW, Xie SM, Li HY, Zhong XY.
    Neuropathology; 2014 Apr 15; 34(2):128-34. PubMed ID: 24112388
    [Abstract] [Full Text] [Related]

  • 20. Predicting and monitoring response to chemotherapy by 1,3-bis(2-chloroethyl)-1-nitrosourea in subcutaneously implanted 9L glioma using the apparent diffusion coefficient of water and 23Na MRI.
    Babsky AM, Hekmatyar SK, Zhang H, Solomon JL, Bansal N.
    J Magn Reson Imaging; 2006 Jul 15; 24(1):132-9. PubMed ID: 16758478
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.